Literature DB >> 12096174

Health behaviors and health status of older women with schizophrenia.

Faith B Dickerson1, Andrea Pater, Andrea E Origoni.   

Abstract

The authors interviewed 43 women with schizophrenia who were 40 to 70 years of age about their health status, preventive health care, addictive behaviors, and comorbid medical conditions. Data were compared with those for age-matched samples from the general population. Thirty women in the study sample (71 percent) were overweight or obese, compared with 38 percent in the general population. Twenty-seven (63 percent) smoked cigarettes. Twenty-six women (62 percent) had received a mammogram in the past two years, compared with 86 percent in the general population. Rates of routine physical examinations and Pap tests did not differ markedly between the study sample and the general population. These results highlight the health impairments of older women who have schizophrenia.

Entities:  

Mesh:

Year:  2002        PMID: 12096174     DOI: 10.1176/appi.ps.53.7.882

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  10 in total

1.  Are women with psychosis receiving adequate cervical cancer screening?

Authors:  Devon Tilbrook; Jane Polsky; Aisha Lofters
Journal:  Can Fam Physician       Date:  2010-04       Impact factor: 3.275

2.  Breast Cancer Screening in Women With Schizophrenia: A Systematic Review and Meta-Analysis.

Authors:  Alison Hwong; Kara Wang; Stephen Bent; Christina Mangurian
Journal:  Psychiatr Serv       Date:  2019-11-14       Impact factor: 3.084

3.  Medication adherence among older adults with schizophrenia.

Authors:  Heather C Leutwyler; Patrick J Fox; Margaret Wallhagen
Journal:  J Gerontol Nurs       Date:  2013-01-18       Impact factor: 1.254

4.  Health behavior risk factors across age as predictors of cardiovascular disease diagnosis.

Authors:  Michelle Cardi; Niki Munk; Faika Zanjani; Tina Kruger; K Warner Schaie; Sherry L Willis
Journal:  J Aging Health       Date:  2009-06-10

5.  Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study.

Authors:  Daniel E Casey; Earl E Sands; Jens Heisterberg; Hwa-Ming Yang
Journal:  Psychopharmacology (Berl)       Date:  2008-07-04       Impact factor: 4.530

6.  Effect of health-related quality of life on women and men's Veterans Affairs (VA) health care utilization and mortality.

Authors:  Jasvinder A Singh; Maureen Murdoch
Journal:  J Gen Intern Med       Date:  2007-07-03       Impact factor: 5.128

Review 7.  Health habits of patients with schizophrenia.

Authors:  Christiane Roick; Anita Fritz-Wieacker; Herbert Matschinger; Dirk Heider; Jana Schindler; Steffi Riedel-Heller; Matthias C Angermeyer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-02-13       Impact factor: 4.519

8.  Schizophrenia and potentially preventable hospitalizations in the United States: a retrospective cross-sectional study.

Authors:  Elizabeth Khaykin Cahoon; Emma E McGinty; Daniel E Ford; Gail L Daumit
Journal:  BMC Psychiatry       Date:  2013-01-25       Impact factor: 3.630

9.  Mammography stages of change in middle-aged women with schizophrenia: an exploratory analysis.

Authors:  Laurie A Lindamer; Emily Wear; Georgia Robins Sadler
Journal:  BMC Psychiatry       Date:  2006-10-30       Impact factor: 3.630

Review 10.  Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis.

Authors:  David P J Osborn; Christine A Wright; Gus Levy; Michael B King; Raman Deo; Irwin Nazareth
Journal:  BMC Psychiatry       Date:  2008-09-25       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.